Common TitleNIAID SYNERGY (Genotype 4)
Official Title Ledipasvir and Sofosbuvir for Hepatitis C Genotype 4: a Proof-of-Concept, Single-Centre, Open-Label Phase 2a Cohort Study
Phase Phase II
ClinicalTrials.gov NCT01805882
Treatments
Ledipasvir-Sofosbuvir
Ledipasvir-Sofosbuvir
Tradename:HarvoniOther Names:LDV-SOFClass:FDA-ApprovedFunding
Non-IndustryNational Institute of Allergy and Infectious Diseases (NIAID)